Xeljanz XR 11 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FY7SX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,199
Award facts
- Contract value 100% obligated
- $3,198.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for $3,198.50 to supply XELJANZ XR 11 MG tablets (30-count unit dose packaging). This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open procurement. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of July 15, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's contract portfolio with the Defense Logistics Agency demonstrates extensive capability to supply a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains. The DLA Troop Support Medical contract enables AmerisourceBergen to deliver specialty medications, brand-name and generic drugs, vaccines, and related medical commodities to support Defense Health Agency operations and other federal healthcare systems worldwide, positioning the company as a key strategic partner in the military healthcare supply chain.
Quick answers
Who was awarded contract SPE2DB25FY7SX?
SPE2DB25FY7SX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 14, 2025.
How much is contract SPE2DB25FY7SX worth?
The government has obligated $3,199 on SPE2DB25FY7SX.
Is contract SPE2DB25FY7SX an order under another contract?
Yes. SPE2DB25FY7SX is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB25FY7SX competed?
The extent of competition for SPE2DB25FY7SX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award